Moderna shares double as cancer vaccine data rekindles investor hopes
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Merck, Moderna claim 'promising' skin cancer vaccine results in key trial medicalxpress.com
- mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say arstechnica.com
- Merck, Moderna claim 'promising' skin cancer vaccine results in key trial iol.co.za
- Merck, Moderna claim ‘promising’ skin cancer vaccine results in key trial torontosun.com
- Moderna shares double as cancer vaccine data rekindles investor hopes investing.com
